Portwood Charles A

Avg. Two Year Performance

No purchase track record
25% Avg. Sale Return
12% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(4%)3%12%17%25%
Sale Success Rate0 of 21 of 22 of 22 of 22 of 2

Wyeth

Drugs » Drug Manufacturers - Major

Exec. VP TO&PS:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--